Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
Primary Purpose
Spinal Cord Injuries
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Open-loop Stimulation
Close-loop Stimulation
Functional Task Practice
Sponsored by
About this trial
This is an interventional treatment trial for Spinal Cord Injuries
Eligibility Criteria
Inclusion Criteria:
- has cervical (C8 or higher), incomplete (American Spinal Cord Injury Impairment Scale - C or D) traumatic spinal cord injury, minimum 1-year post-injury
- has difficulty with hand functions in activities of daily living (e.g., dressing, grooming, feeding)
- stable medical condition without cardiopulmonary disease or autonomic dysreflexia that would contraindicate participation in upper extremity rehabilitation or testing activities
- capable of performing simple cued motor tasks
- has ability to attend intervention/functional task training and assessment sessions 3 times/week
- has adequate social support to participate in all intervention and baseline/follow-up assessment sessions throughout 40 weeks.
- has ability to read and speak English
Exclusion Criteria:
- dependent on ventilation support
- has implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
- has metallic devices and implants in the head (e.g., deep brain stimulators, aneurysm clips/coils, and stents, vagus nerve stimulators)
- has a history or current signs/symptoms of syringomyelia (progressive pain, muscle weakness, and/or sensory loss; deterioration of bowel/bladder function)
- has autoimmune etiology of spinal cord dysfunction/injury
- has received botulinum toxin injections in upper extremity muscles in the prior 6 months
- has tendon transfer or nerve transfer surgery in the upper extremity,
- taking tizanidine, dantrolene or diazepam
- has history of seizures or increased risk for seizures
- has history of chronic headaches or migraines
- has history of neurologic diseases, such as stroke, multiple sclerosis, traumatic brain injury, etc.
- has peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc.)
- has rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
- has significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation
- has cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention
- unhealed fracture, contracture, pressure sore, or frequent urinary tract infections or other illnesses that might interfere with upper extremity rehabilitation or testing activities
- has a history of severe allergy (i.e., allergic reaction that could not be treated with antihistaminic medication
- has alcohol and/or drug abuse (subject's verbal statement)
- has cancer
- pregnant (Childbearing potential will be asked at screening, baseline, and every subsequent visit in which the subject would receive transcutaneous spinal cord stimulation and/or Transcranial Magnetic Stimulation whether the participant could be pregnant. Pregnancy will be ruled out by an over-the-counter urine pregnancy test for all females of childbearing potential (1) at the time of enrollment, (2) prior to all sessions that include Transcranial Magnetic Stimulation, and also prior to the intervention phases of (3) closed-loop or (4) open-loop stimulation. Additional pregnancy tests may be performed if there is a concern of pregnancy.)
- lack of ability to fully comprehend, cooperate and/or safely perform study procedures in the investigator's opinion/judgment
- unable to read and/or comprehend the consent form
Sites / Locations
- University of WashingtonRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Open-loop Stimulation
Close-loop Stimulation
Arm Description
Continuous stimulation
Intended movement-based stimulation.
Outcomes
Primary Outcome Measures
Change from baseline- Graded Redefined Assessment of Strength, Sensation, and Prehension version 2
Measurement of upper limb strength, sensation, qualitative prehension, and quantitative prehension (range 0-188, higher score mean better outcome)
Change from baseline- Capabilities of Upper Extremity Test
Measures unilateral and bilateral hand and arm function (range 0-128, higher score mean better outcome)
Change from baseline- Grip and Pinch Force
Grip and pinch force measurement using a dynamometer (higher score mean better outcome)
Change from baseline- Modified Ashworth Scale
Clinician administered assessment of spasticity (range 0-4, lower score mean better outcome)
Secondary Outcome Measures
Change from baseline- International Standards for Neurologic Classification of Spinal Cord Injury - Motor Score
Standard manual muscle strength examination (Range 0-100 points, higher score mean better outcome)
Change from baseline- International Standards for Neurologic Classification of Spinal Cord Injury - Sensory Score
Standard examination of dermatomal sensation (range 0-224 points, higher score mean better outcome)
Change from baseline- International Standards of Autonomic Functions after Spinal Cord Injury
Clinician assessment to document remaining autonomic functions after spinal cord injury
Change from baseline- H-Reflex
Electrophysiologic measurement of H-reflex (lower Hmax/Mmax ratio mean better outcome)
Change from baseline- Somatosensory Evoked Potentials
Electrophysiologic evaluation of sensory pathways between the brain and the limb (shorter latency mean better outcome)
Change from baseline- Motor Evoked Potentials
Electrophysiologic evaluation of motor pathways between the brain and the muscles (higher amplitude mean better outcome)
Change from baseline Spinal Cord Independence Measure Self Report
Quantification of the level of independence in daily activities (range 0-100 points, higher score mean better outcome)
Full Information
NCT ID
NCT05267951
First Posted
October 15, 2021
Last Updated
October 13, 2022
Sponsor
University of Washington
1. Study Identification
Unique Protocol Identification Number
NCT05267951
Brief Title
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
Official Title
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 12, 2022 (Actual)
Primary Completion Date
August 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to assess the efficacy of non-invasive (transcutaneous) closed-loop electrical spinal cord stimulation for recovery of upper limb function (Aim 1) and spasticity (Aim 2) following spinal cord injury.
Detailed Description
After being informed about the purpose, study timeline, and procedures, all participants giving written informed consent will undergo repeated baseline measurements throughout four weeks, followed by intensive exercise therapy for six weeks.
Next, participants will receive (1) closed-loop stimulation and (2) open-loop stimulation treatment for Aim 1 Section of the study. Stimulation will be delivered non-invasively using skin electrodes on the back of the neck. Each treatment arm will last six weeks. The investigators will determine the order of the treatment arms randomly. For closed-loop stimulation, The investigators will place a sensor on the arm muscles over the skin. This sensor will detect the movement and start the stimulation accordingly.
For Aim 2 Section, intervention arms will consist of (1) transcutaneous stimulation, followed by (2) spasticity-reducing stimulation treatment arms.
There will be a 6-week waiting period between two stimulation arms where participants will not receive any stimulation or exercise therapy. Treatments will last 90 minutes per session, three sessions per week. Overall participation in the study will last ten months: Four weeks baseline + three treatment periods (each will last six weeks) + six weeks waiting period between stimulation treatments + 12 weeks follow-up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Participants who participate in Aim 1 Section of the study will receive open-loop and closed-loop stimulation intervention arms in a randomized order.
The order of the two interventions in the Aim 2 Section of the study will be the same for all participants enrolled in the Aim 2 Section of the study.
Masking
Outcomes Assessor
Masking Description
Functional measurements and all other assessments will be done by an examiner who does not know the order of the intervention arm.
Allocation
Randomized
Enrollment
9 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Open-loop Stimulation
Arm Type
Experimental
Arm Description
Continuous stimulation
Arm Title
Close-loop Stimulation
Arm Type
Experimental
Arm Description
Intended movement-based stimulation.
Intervention Type
Device
Intervention Name(s)
Open-loop Stimulation
Intervention Description
Spinal cord stimulation will be applied continuously over the skin throughout the intervention session.
Intervention Type
Device
Intervention Name(s)
Close-loop Stimulation
Intervention Description
Spinal cord stimulation will start and stop based on the signals that come from the sensors placed on upper limb muscle surfaces.
Intervention Type
Other
Intervention Name(s)
Functional Task Practice
Other Intervention Name(s)
Intensive exercise therapy
Intervention Description
Exercise therapy consists of repeated functional hand and arm movements
Primary Outcome Measure Information:
Title
Change from baseline- Graded Redefined Assessment of Strength, Sensation, and Prehension version 2
Description
Measurement of upper limb strength, sensation, qualitative prehension, and quantitative prehension (range 0-188, higher score mean better outcome)
Time Frame
"Repeated measurements once every two weeks throughout the study, an average of 10 months".
Title
Change from baseline- Capabilities of Upper Extremity Test
Description
Measures unilateral and bilateral hand and arm function (range 0-128, higher score mean better outcome)
Time Frame
"Repeated measurements once every two weeks throughout the study, an average of 10 months".
Title
Change from baseline- Grip and Pinch Force
Description
Grip and pinch force measurement using a dynamometer (higher score mean better outcome)
Time Frame
"Repeated measurements once every two weeks throughout the study, an average of 10 months".
Title
Change from baseline- Modified Ashworth Scale
Description
Clinician administered assessment of spasticity (range 0-4, lower score mean better outcome)
Time Frame
"Repeated measurements once every two weeks throughout the study, an average of 10 months".
Secondary Outcome Measure Information:
Title
Change from baseline- International Standards for Neurologic Classification of Spinal Cord Injury - Motor Score
Description
Standard manual muscle strength examination (Range 0-100 points, higher score mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Title
Change from baseline- International Standards for Neurologic Classification of Spinal Cord Injury - Sensory Score
Description
Standard examination of dermatomal sensation (range 0-224 points, higher score mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Title
Change from baseline- International Standards of Autonomic Functions after Spinal Cord Injury
Description
Clinician assessment to document remaining autonomic functions after spinal cord injury
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Title
Change from baseline- H-Reflex
Description
Electrophysiologic measurement of H-reflex (lower Hmax/Mmax ratio mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Title
Change from baseline- Somatosensory Evoked Potentials
Description
Electrophysiologic evaluation of sensory pathways between the brain and the limb (shorter latency mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Title
Change from baseline- Motor Evoked Potentials
Description
Electrophysiologic evaluation of motor pathways between the brain and the muscles (higher amplitude mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Title
Change from baseline Spinal Cord Independence Measure Self Report
Description
Quantification of the level of independence in daily activities (range 0-100 points, higher score mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Other Pre-specified Outcome Measures:
Title
Change from baseline- World Health Organization Quality of Life Questionnaire
Description
Self-reported questionnaire on quality of life (range 0-100 points, higher score mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Title
Change from baseline- Spinal Cord Injury - Functional Index Short-Form
Description
Patient-reported questionnaire (range 0-100 points, higher score mean better outcome)
Time Frame
"Baseline"/"At the end of each treatment arm"/"Through study completion"
Title
Change from baseline- International Spinal Cord Injury Bowel Function Basic Data Set.v.2.1
Description
Patient-reported questionnaire (range 0-47 points, lower score mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
Title
Change from baseline- Patient Reported Impact of Spasticity Measure
Description
Patient-reported questionnaire (range 0-164 points, lower score mean better outcome)
Time Frame
"Repeated measurements once every eight weeks throughout the study, an average of 10 months".
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
has cervical (C8 or higher), incomplete (American Spinal Cord Injury Impairment Scale - C or D) traumatic spinal cord injury, minimum 1-year post-injury
has difficulty with hand functions in activities of daily living (e.g., dressing, grooming, feeding)
stable medical condition without cardiopulmonary disease or autonomic dysreflexia that would contraindicate participation in upper extremity rehabilitation or testing activities
capable of performing simple cued motor tasks
has ability to attend intervention/functional task training and assessment sessions 3 times/week
has adequate social support to participate in all intervention and baseline/follow-up assessment sessions throughout 40 weeks.
has ability to read and speak English
Exclusion Criteria:
dependent on ventilation support
has implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
has metallic devices and implants in the head (e.g., deep brain stimulators, aneurysm clips/coils, and stents, vagus nerve stimulators)
has a history or current signs/symptoms of syringomyelia (progressive pain, muscle weakness, and/or sensory loss; deterioration of bowel/bladder function)
has autoimmune etiology of spinal cord dysfunction/injury
has received botulinum toxin injections in upper extremity muscles in the prior 6 months
has tendon transfer or nerve transfer surgery in the upper extremity,
taking tizanidine, dantrolene or diazepam
has history of seizures or increased risk for seizures
has history of chronic headaches or migraines
has history of neurologic diseases, such as stroke, multiple sclerosis, traumatic brain injury, etc.
has peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc.)
has rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
has significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation
has cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention
unhealed fracture, contracture, pressure sore, or frequent urinary tract infections or other illnesses that might interfere with upper extremity rehabilitation or testing activities
has a history of severe allergy (i.e., allergic reaction that could not be treated with antihistaminic medication
has alcohol and/or drug abuse (subject's verbal statement)
has cancer
pregnant (Childbearing potential will be asked at screening, baseline, and every subsequent visit in which the subject would receive transcutaneous spinal cord stimulation and/or Transcranial Magnetic Stimulation whether the participant could be pregnant. Pregnancy will be ruled out by an over-the-counter urine pregnancy test for all females of childbearing potential (1) at the time of enrollment, (2) prior to all sessions that include Transcranial Magnetic Stimulation, and also prior to the intervention phases of (3) closed-loop or (4) open-loop stimulation. Additional pregnancy tests may be performed if there is a concern of pregnancy.)
lack of ability to fully comprehend, cooperate and/or safely perform study procedures in the investigator's opinion/judgment
unable to read and/or comprehend the consent form
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Fatma Inanici, MD., Ph.D.
Phone
206 787 2692
Email
finanici@uw.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chet Moritz, Ph.D.
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Washington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fatma Inanici, MD, Ph.D.
Phone
206-787-2692
Email
finanici@uw.edu
First Name & Middle Initial & Last Name & Degree
Chet T. Moritz, PhD
First Name & Middle Initial & Last Name & Degree
Fatma Inanici, MD, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29877852
Citation
Inanici F, Samejima S, Gad P, Edgerton VR, Hofstetter CP, Moritz CT. Transcutaneous Electrical Spinal Stimulation Promotes Long-Term Recovery of Upper Extremity Function in Chronic Tetraplegia. IEEE Trans Neural Syst Rehabil Eng. 2018 Jun;26(6):1272-1278. doi: 10.1109/TNSRE.2018.2834339.
Results Reference
background
PubMed Identifier
33400652
Citation
Inanici F, Brighton LN, Samejima S, Hofstetter CP, Moritz CT. Transcutaneous Spinal Cord Stimulation Restores Hand and Arm Function After Spinal Cord Injury. IEEE Trans Neural Syst Rehabil Eng. 2021;29:310-319. doi: 10.1109/TNSRE.2021.3049133. Epub 2021 Mar 2.
Results Reference
background
PubMed Identifier
26371306
Citation
McPherson JG, Miller RR, Perlmutter SI. Targeted, activity-dependent spinal stimulation produces long-lasting motor recovery in chronic cervical spinal cord injury. Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):12193-8. doi: 10.1073/pnas.1505383112. Epub 2015 Sep 14.
Results Reference
background
Learn more about this trial
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
We'll reach out to this number within 24 hrs